Specialised pro-resolving mediators of inflammation in inflammatory arthritis

被引:100
|
作者
Barden, Anne E. [1 ]
Moghaddami, Mahin [2 ,3 ]
Mas, Emilie [1 ]
Phillips, Michael [4 ]
Cleland, Leslie G. [2 ,3 ]
Mori, Trevor A. [1 ]
机构
[1] Univ Western Australia, Royal Perth Hosp Unit, Sch Med & Pharmacol, GPO Box X2213, Perth, WA 6847, Australia
[2] Royal Adelaide Hosp, Rheumatol Unit, North Terrace, Adelaide, SA, Australia
[3] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia
[4] Harry Perkins Inst Med Res, Perth, WA, Australia
关键词
Arthritis; Synovial fluid; Specialised pro-resolving mediators; Resolvins; Pain; Fish oil; DIETARY FISH-OIL; POLYUNSATURATED FATTY-ACIDS; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; SUPPLEMENTATION; RESOLUTION; BLOOD; D1;
D O I
10.1016/j.plefa.2016.03.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Specialised pro-resolving mediators (SPM) are derived from n-3 long chain polyunsaturated fatty acids (n-3FA). They promote resolution of inflammation and may contribute to the beneficial effects of n-3FA in patients with arthritis. This study compared SPM in knee effusions and plasma of patients with arthritis taking n-3FA, and plasma of healthy volunteers taking n-3FA. Methods: Thirty six patients taking n-3FA undergoing arthrocentesis for an inflammatory knee effusion and 36 healthy volunteers who had taken n-3FA (2.4 g/day) for 4 weeks were studied. SPM in synovial fluid and plasma were measured by liquid chromatography-tandem mass spectrometry included 18-hydroxyeicosapentaenoic acid (18-HEPE), the precursor of the E-series SPM (RvE1, RvE2, RvE3, 18R-RvE3), and 17-hydroxydocosahexaenoic acid (17-HDHA), the precursor of the D-series SPM (RvD1, 17R-RvD1, RvD2). Other SPM included protectin D1 (PD1), 10S,17S-dihydroxydocosahexaenoic acid (10,17S-DHDHA), maresin-1 (MaR-1) and 14-hydroxydocosahexaenoic acid (14-HDHA) derived from docosahexaenoic acid (DHA). Results: E- and D-series SPM and the precursors 18-HEPE and 17-HDHA were present in synovial fluid and plasma of the patients with inflammatory arthritis. Plasma SPM were negatively related to erythrocyte sedimentation rate in arthritis patients (P < 0.01) and synovial fluid RvE2 was negatively associated with pain score (P=0.02). Conversion from 18-HEPE and 17-HDHA to E- and D-series SPM was greater in synovial fluid (P < 0.01). Most plasma SPM in arthritis patients were elevated (P < 0.05) compared with healthy volunteers, and conversion to E- and D-series SPM was greater (P < 0.01). Conclusions: SPM are present in chronic knee effusions and although the levels are lower than in plasma, the association between synovial fluid RvE2 and reduced pain scores suggests that synthesis of SPM at the site of inflammation is a relevant mechanism by which n-3FA alleviate the symptoms of arthritis. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:24 / 29
页数:6
相关论文
共 50 条
  • [1] EXPRESSION OF PRO-RESOLVING SPECIALISED MEDIATORS' RECEPTORS IN RHEUMATOID ARTHRITIS
    Perniola, S.
    Dinoia, L.
    Lacarpia, N.
    Natuzzi, D.
    Bizzoca, R.
    Lannone, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1259 - 1259
  • [2] SPECIALISED PRO-RESOLVING LIPID MEDIATORS IN CHRONIC INFLAMMATION: A COMPARISON BETWEEN RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS
    Jonasdottir, H. S.
    Brouwers, H.
    Kwekkeboom, J. C.
    Huizinga, T. W.
    Kloppenburg, M.
    Toes, R. E.
    Giera, M.
    Ioan-Facsinay, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A64 - A64
  • [3] Advances in the Chemistry and Biology of Specialised Pro-Resolving Mediators (SPMs)
    Byrne, Lucy
    Guiry, Patrick J.
    MOLECULES, 2024, 29 (10):
  • [4] Pro-resolving lipid mediators in allergic inflammation
    Barnig, C.
    REVUE FRANCAISE D ALLERGOLOGIE, 2016, 56 (01): : 38 - 42
  • [5] The role of specialized pro-resolving mediators (SPMs) in inflammatory arthritis: A therapeutic strategy
    Natami, Mohammad
    Hosseini, Seyed Mehdi
    Khaleel, Raghad Abdulsalam
    Addulrahman, Tamara Shamil
    Zarei, Mehdi
    Asadi, Sahar
    Gholami, Sepideh
    Mehrvar, Amir
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2024, 170
  • [6] Specialised pro-resolving mediators: the magic bullet for perioperative neurocognitive disorders?
    Li, Rong
    Lai, Ieng Kit
    Maze, Mervyn
    BRITISH JOURNAL OF ANAESTHESIA, 2019, 122 (03) : 292 - 294
  • [7] Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
    Serhan, Charles N.
    Levy, Bruce D.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (07): : 2657 - 2669
  • [8] Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention
    Dalli, Jesmond
    Kitch, Douglas
    Brien, Meagan P.
    Hunt, Peter W.
    Funderburg, Nicholas
    Moisi, Daniela
    Gupta, Amita
    Brown, Todd T.
    Tien, Phyllis C.
    Aberg, Judith A.
    Shivakoti, Rupak
    EBIOMEDICINE, 2023, 89
  • [9] Pro-resolving lipid mediators attenuate lung inflammation
    Phipps, Richard
    Thatcher, Thomas
    Hsiao, Hsi-Min
    Serhan, Charles
    Sime, Patricia
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [10] Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
    Basil, Maria C.
    Levy, Bruce D.
    NATURE REVIEWS IMMUNOLOGY, 2016, 16 (01) : 51 - 67